Abbott Labs' surprise guidance bump is a major positive for its shareholders
We also love that EPS results on Tuesday came in above the range management had forecasted.
Tekef
0
39
An Abbott Labs employee gets the BinaxNOW rapid Covid-19 antigen test at her workplace.
Abbott Labs
Abbott Laboratories delivered a top and bottom line beat Wednesday and surprised investors by raising its full-year guidance — a show of confidence by the medical device maker not seen in a first quarter since 2016.
